JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M402496200 on April 13, 2004

J. Biol. Chem., Vol. 279, Issue 26, 27302-27314, June 25, 2004
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
279/26/27302    most recent
M402496200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Patenaude, A.
Right arrow Articles by Mirault, M.-E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Patenaude, A.
Right arrow Articles by Mirault, M.-E.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Mitochondrial Thioredoxin System

EFFECTS OF TrxR2 OVEREXPRESSION ON REDOX BALANCE, CELL GROWTH, AND APOPTOSIS*

Alexandre Patenaude{ddagger}§, M. R. Ven Murthy¶, and Marc-Edouard Mirault{ddagger}§||

From the Departments of {ddagger}Medicine and Medical Biology, Faculty of Medicine, Laval University, and §CHUL/CHUQ Medical Research Center, Québec City, Québec G1V 4G2, Canada

Thioredoxin-2 (Trx2) is a mitochondrial protein-disulfide oxidoreductase essential for control of cell survival during mammalian embryonic development. This suggests that mitochondrial thioredoxin reductase-2 (TrxR2), responsible for reducing oxidized Trx2, may also be a key player in the regulation of mitochondria-dependent apoptosis. With this in mind, we investigated the effects of overexpression of TrxR2, Trx2, or both on mammalian cell responses to various apoptotic inducers. Stable transfectants of mouse Neuro2A cells were generated that overexpressed TrxR2 or an EGFP-TrxR2 fusion protein. EGFP-TrxR2 was enzymatically active and was localized in mitochondria. TrxR2 protein level and TrxR activity could be increased up to 6-fold in mitochondria. TrxR2 and EGFP-TrxR2 transfectants showed reduced growth rates as compared with control cells. This growth alteration was not due to cytotoxic effects nor related to changes in basal mitochondrial transmembrane potential ({Delta}{Psi}m), reactive oxygen species production, or to other mitochondrial antioxidant components such as Trx2, peroxyredoxin-3, MnSOD, GPx1, and glutathione whose levels were not affected by increased TrxR2 activity. In response to various apoptotic inducers, the extent of {Delta}{Psi}m dissipation, reactive oxygen species induction, caspase activation, and loss of viability were remarkably similar in TrxR2 and control transfectants. Excess TrxR2 did not prevent trichostatin A-mediated neuronal differentiation of Neuro2A cells nor did it protect them against {beta}-amyloid neurotoxicity. Neither massive glutathione depletion nor co-transfection of Trx2 and TrxR2 in Neuro2A (mouse), COS-7 (monkey), or HeLa (human) cells revealed any differential cellular resistance to prooxidant or non-oxidant apoptotic stimuli. Our results suggest that neither Trx2 nor TrxR2 gain of function modified the redox regulation of mitochondria-dependent apoptosis in these mammalian cells.


Received for publication, March 4, 2004

* This work was supported by National Institutes of Health Grant RO1NS37718 and Subcontract NMRI98001 with the Natural Medicines Research Institute (to M. R. V. M. and M.-E. M.), and by the National Cancer Institute of Canada through Canadian Cancer Society Grants 2796 and 3488 (to M.-E. M.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

|| To whom correspondence should be addressed: Dept. of Medicine, Entre Hospitalier de Laval University, 2705 Blvd. Laurier, Québec G1V 4G2, Canada. Tel.: 418-656-4141 (ext. 47097); Fax: 418-654-2159; E-mail: memirault{at}crchul.ulaval.ca.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
B. Bogunovic, M. Stojakovic, L. Chen, and M. Maric
An Unexpected Functional Link between Lysosomal Thiol Reductase and Mitochondrial Manganese Superoxide Dismutase
J. Biol. Chem., April 4, 2008; 283(14): 8855 - 8862.
[Abstract] [Full Text] [PDF]


Home page
Molecular Cancer TherapeuticsHome page
L. Negroni, M. Samson, J.-M. Guigonis, B. Rossi, V. Pierrefite-Carle, and C. Baudoin
Treatment of colon cancer cells using the cytosine deaminase/5-fluorocytosine suicide system induces apoptosis, modulation of the proteome, and Hsp90{beta} phosphorylation
Mol. Cancer Ther., October 1, 2007; 6(10): 2747 - 2756.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
A. F. Baker, T. Landowski, R. Dorr, W. R. Tate, J. M.C. Gard, B. E. Tavenner, T. Dragovich, A. Coon, and G. Powis
The Antitumor Agent Imexon Activates Antioxidant Gene Expression: Evidence for an Oxidative Stress Response
Clin. Cancer Res., June 1, 2007; 13(11): 3388 - 3394.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
A. Patenaude, R. G. Deschesnes, J. L.C. Rousseau, E. Petitclerc, J. Lacroix, M.-F. Cote, and R. C.-Gaudreault
New Soft Alkylating Agents with Enhanced Cytotoxicity against Cancer Cells Resistant to Chemotherapeutics and Hypoxia
Cancer Res., March 1, 2007; 67(5): 2306 - 2316.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
M. Liang and J. L. Pietrusz
Thiol-Related Genes in Diabetic Complications: A Novel Protective Role for Endogenous Thioredoxin 2
Arterioscler. Thromb. Vasc. Biol., January 1, 2007; 27(1): 77 - 83.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
S. Rohrbach, S. Gruenler, M. Teschner, and J. Holtz
The thioredoxin system in aging muscle: key role of mitochondrial thioredoxin reductase in the protective effects of caloric restriction?
Am J Physiol Regulatory Integrative Comp Physiol, October 1, 2006; 291(4): R927 - R935.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
L. Tao, X. Jiao, E. Gao, W. B. Lau, Y. Yuan, B. Lopez, T. Christopher, S. P. RamachandraRao, W. Williams, G. Southan, et al.
Nitrative Inactivation of Thioredoxin-1 and Its Role in Postischemic Myocardial Apoptosis
Circulation, September 26, 2006; 114(13): 1395 - 1402.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
E. I. Biterova, A. A. Turanov, V. N. Gladyshev, and J. J. Barycki
Crystal structures of oxidized and reduced mitochondrial thioredoxin reductase provide molecular details of the reaction mechanism
PNAS, October 18, 2005; 102(42): 15018 - 15023.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
I. Nalvarte, A. E. Damdimopoulos, C. Nystom, T. Nordman, A. Miranda-Vizuete, J. M. Olsson, L. Eriksson, M. Bjornstedt, E. S. J. Arner, and G. Spyrou
Overexpression of Enzymatically Active Human Cytosolic and Mitochondrial Thioredoxin Reductase in HEK-293 Cells: EFFECT ON CELL GROWTH AND DIFFERENTIATION
J. Biol. Chem., December 24, 2004; 279(52): 54510 - 54517.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2004 by the American Society for Biochemistry and Molecular Biology.